Ingredients: 37% conjugated linoleic acid CLA, 14.8% green tea leaf extract (Camellia sinensis (L.) Kuntze), soybean oil, 7.4% L-carnitine, capsule (gelatin, humectant glycerine
In addition, increasing plasma levels of Apo C-III, which inhibits the activity of LPL in individuals with diabetes, can reduce the catabolism of VLDL.[] Additionally, increasing the transfer of fatty acids to the liver, a common disorder in insulin-resistant diabetes, may increase the secretion of VLDL,[ , ] and also its concentration may rise by higher amounts of fatty acids and Apo B100.[] By stimulating and contributing to the decomposition of fatty acids in the mitochondria, L-carnitine can probably reduce the number of fatty acids to produce Lp (a) in patients who are likely to have high atherogenic lipoprotein production
It is not uncommon for a focus predominantly of one cell type, however, to have a small number of a different type
GLP-1 medications produce significantly stronger effects on appetite, blood sugar, and weight loss than berberine does
In clinical trials, participants lost up to 28.7% of their body weight
She was shortlisted for the 2024 George Devine Award
